Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Monoclonal Antibody Service market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Monoclonal Antibody Service Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Monoclonal Antibody Service Market
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
Abbott Laboratories
GSK
BMS
Alexion
UCB
Seattle Genetics
...
Major Type of Monoclonal Antibody Service Covered in Prudent Markets report:
Reagents
Drugs
Other
Application Segments Covered in Prudent Markets Market
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Monoclonal Antibody Service Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Reagents -Product Introduction and Major Manufacturers
1.1.2 Drugs -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Monoclonal Antibody Service Status and Prospect (2015-2026)
2.1.1 China Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.1.2 China Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Monoclonal Antibody Service Status and Prospect (2015-2026)
2.2.1 EU Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.2.2 EU Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Monoclonal Antibody Service Status and Prospect (2015-2026)
2.3.1 USA Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.3.2 USA Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Monoclonal Antibody Service Status and Prospect (2015-2026)
2.4.1 Japan Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.4.2 Japan Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Monoclonal Antibody Service Status and Prospect (2015-2026)
2.5.1 India Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.5.2 India Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Monoclonal Antibody Service Status and Prospect (2015-2026)
2.6.1 Southeast Asia Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Monoclonal Antibody Service Status and Prospect (2015-2026)
2.7.1 South America Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.7.2 South America Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Monoclonal Antibody Service Status and Prospect (2015-2026)
2.8.1 Monoclonal Antibody Service Market Size and Growth Rate (2015-2026)
2.8.2 Monoclonal Antibody Service Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Monoclonal Antibody Service Market Assessment by Segment
3.1 Global Monoclonal Antibody Service Capacity and Growth Rate
3.2 Global Monoclonal Antibody Service Sales by Type
3.3 Global Monoclonal Antibody Service Sales Revenue by Type
3.4 Global Monoclonal Antibody Service Consumption by Application
4 Global Monoclonal Antibody Service Market Assessment by Regions
4.1 Global Monoclonal Antibody Service Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Monoclonal Antibody Service Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Monoclonal Antibody Service Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Monoclonal Antibody Service Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Monoclonal Antibody Service Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Monoclonal Antibody Service Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Monoclonal Antibody Service Sales Market Share of Manufacturers (2019-2020)
6.3 Global Monoclonal Antibody Service Sales Revenue Market Share of Manufacturers (2019-2020)
7 Monoclonal Antibody Service Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer Monoclonal Antibody Service Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche Monoclonal Antibody Service Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Eli Lilly
7.3.1 Eli Lilly Company Profiles
7.3.2 Eli Lilly Product Introduction
7.3.3 Eli Lilly Monoclonal Antibody Service Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Bayer
7.4.1 Bayer Company Profiles
7.4.2 Bayer Product Introduction
7.4.3 Bayer Monoclonal Antibody Service Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Amgen
7.5.1 Amgen Company Profiles
7.5.2 Amgen Product Introduction
7.5.3 Amgen Monoclonal Antibody Service Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Sanofi-Aventis
7.6.1 Sanofi-Aventis Company Profiles
7.6.2 Sanofi-Aventis Product Introduction
7.6.3 Sanofi-Aventis Monoclonal Antibody Service Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Profiles
7.7.2 Johnson & Johnson Product Introduction
7.7.3 Johnson & Johnson Monoclonal Antibody Service Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Profiles
7.8.2 Novo Nordisk Product Introduction
7.8.3 Novo Nordisk Monoclonal Antibody Service Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Merck
7.9.1 Merck Company Profiles
7.9.2 Merck Product Introduction
7.9.3 Merck Monoclonal Antibody Service Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Profiles
7.10.2 Abbott Laboratories Product Introduction
7.10.3 Abbott Laboratories Monoclonal Antibody Service Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 GSK
7.12 BMS
7.13 Alexion
7.14 UCB
7.15 Seattle Genetics
8 Conclusion